Everything about GI254023X
The trial satisfied its Main endpoint by demonstrating that in people with NASH and mild to average fibrosis all regimens have been very well tolerated. The commonest adverse activities (AEs) have been gastrointestinal. Small pruritus (itching) was noticed in people today addressed with cilofexor. Across all teams, five–14% of men and women disco